STOCK TITAN

MARPAI INC A - MRAI STOCK NEWS

Welcome to our dedicated page for MARPAI A news (Ticker: MRAI), a resource for investors and traders seeking the latest updates and insights on MARPAI A stock.

Marpai Inc. (Nasdaq: MRAI) is a leading, national Third-Party Administration (TPA) company focused on transforming the $22 billion TPA market. Operating at the intersection of healthcare and deep learning, Marpai's mission is to predict and prevent costly events in healthcare for patients, providers, and payors. The company provides value-oriented health plan services to employers that directly pay for employee health benefits, leveraging advanced artificial intelligence to improve healthcare outcomes and reduce costs.

Marpai operates nationwide, offering access to leading provider networks including Aetna and Cigna. The company’s services include plan administration, claims processing, and wellness initiatives, all designed to deliver the healthiest member population for the health plan budget. Through its Marpai Saves initiative, Marpai aims to enhance the quality of care while maintaining cost-efficiency.

Recent achievements include the successful acquisition and integration of Maestro Health, which has begun to yield synergies and operational improvements. Additionally, Marpai secured an $11.83 million convertible note to repay existing debt and fuel growth initiatives, further solidifying its financial standing.

Despite some challenges with Nasdaq listing requirements, Marpai has strategically decided to transition its stock listing to OTCQX Market. This move is expected to reduce compliance costs and allow the company to focus on growth and shareholder value. The company remains committed to its mission and continues to innovate and expand its service offerings in the TPA sector.

Marpai's financial outlook remains strong, with recent cost reduction initiatives expected to generate $3 million in annual savings, positioning the company for profitability and sustainable growth. The company continually adapts to market demands, enhancing its operational efficiency and client satisfaction.

Rhea-AI Summary
Marpai, Inc. (Nasdaq: MRAI) announced the addition of two new independent directors to its Board of Directors, Jennifer Calabrese and Robert Pons, as part of the Company's transformation plan and commitment to strong corporate governance and shareholder value creation. The Board will implement a strategic plan to enhance the Company's performance and drive shareholder value creation, positioning Marpai for near- and long-term success.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
16.18%
Tags
management
-
Rhea-AI Summary
Marpai, Inc. (Nasdaq: MRAI) has announced that it has regained compliance with Nasdaq's minimum bid price requirement, closing the matter.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.45%
Tags
none
-
Rhea-AI Summary
Marpai, Inc. (Nasdaq: MRAI) has requested a hearing before the Nasdaq Listing Qualifications Panel to appeal the determination by the Listing Qualifications Department of The Nasdaq Stock Market and request a further extension of time to regain compliance with Nasdaq Listing 5550(b)(2). The requested appeal stays any delisting or suspension action pending the issuance of a final decision by the Panel, which has broad discretionary public interest authority. The Panel can grant the Company up to an additional 180 calendar days to regain compliance, but there is no guarantee that the Panel will grant an extension of the compliance period.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
32%
Tags
none
Rhea-AI Summary
Marpai, Inc. (Marpai) (Nasdaq: MRAI) to host Investors Webcast on November 29, 2023, to discuss recent management changes, withdrawal of S-1 Registration, current initiatives, and strategic vision.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.96%
Tags
conferences
-
Rhea-AI Summary
Marpai, Inc. (Nasdaq: MRAI) reported a 77% increase in total revenue for the third quarter of 2023, reaching $8.7 million, driven by the acquisition of Maestro Health. However, the company experienced an operating loss of $7.0 million and a net loss of $7.3 million during the same period. The withdrawal of the Form S-1 Registration Statement and the suspension of financial guidance for 2023 due to adverse market conditions were also highlighted.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary
Marpai, Inc. announces Damien Lamendola as new CEO and Steve Johnson as CFO. Mike Dendy joins the board. Lamendola is the largest shareholder and a healthcare industry entrepreneur. Marpai aims to create value and reduce healthcare costs through its services.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-11.67%
Tags
none
Rhea-AI Summary
Marpai, Inc. (MRAI) Reports Second Quarter 2023 Financial Results, Net Revenue Increases by 3.8%, Operating Loss Improves, and Net Loss Decreases. The company also disclosed a public offering of 1,850,000 shares of common stock at a public offering price of $4.00 per share, for gross proceeds of $7.4 million.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.18%
Tags
-
Rhea-AI Summary
Marpai, Inc. (Nasdaq: MRAI) to host conference call and webcast on August 3 to discuss deep learning technology in self-funded health insurance market
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.56%
Tags
conferences earnings
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
14.97%
Tags
none

FAQ

What is the current stock price of MARPAI A (MRAI)?

The current stock price of MARPAI A (MRAI) is $1.0825 as of December 24, 2024.

What is the market cap of MARPAI A (MRAI)?

The market cap of MARPAI A (MRAI) is approximately 6.7M.

What does Marpai Inc. do?

Marpai Inc. is a national Third-Party Administration (TPA) company that provides health plan services to self-funded employers, utilizing advanced AI to improve healthcare outcomes and reduce costs.

What is Marpai’s mission?

Marpai’s mission is to predict and prevent costly healthcare events for patients, providers, and payors, improving overall healthcare quality and cost-efficiency.

What recent achievements has Marpai reported?

Marpai has successfully integrated Maestro Health, secured $11.83 million in convertible notes, and implemented cost reduction initiatives expected to save $3 million annually.

How does Marpai use artificial intelligence?

Marpai uses advanced deep learning to predict and prevent costly healthcare events, enhancing the quality of care and reducing costs for members.

What provider networks does Marpai work with?

Marpai offers access to leading provider networks including Aetna and Cigna, among others.

Why is Marpai transitioning to the OTCQX Market?

Marpai is moving to OTCQX to reduce compliance costs and better focus on growth and shareholder value, following challenges with Nasdaq listing requirements.

What financial outlook has Marpai provided recently?

Marpai expects to generate $3 million in annual savings from recent cost reduction initiatives and continues to focus on operational efficiency and profitability.

What are the key services provided by Marpai?

Marpai provides health plan administration, claims processing, and wellness initiatives aimed at improving member health and reducing costs.

How does Marpai ensure high-quality healthcare?

Through its Marpai Saves initiative, the company leverages AI and analytics to deliver high-quality, cost-effective healthcare solutions tailored to self-funded employers.

What is Marpai’s approach to growth and innovation?

Marpai continuously adapts to market demands, enhances operational efficiency, and invests in innovative AI solutions to improve healthcare outcomes and drive growth.

MARPAI INC A

Nasdaq:MRAI

MRAI Rankings

MRAI Stock Data

6.70M
4.05M
63.71%
13.56%
0.16%
Healthcare Plans
Services-misc Health & Allied Services, Nec
Link
United States of America
TAMPA